Evolution of Immune Intelligent Immunotherapy

Omid Hamid, MD
Chief, Translational Research & Immuno-Oncology
Immunotherapy has revolutionized the landscape of cancer treatment, offering new and effective treatment options for a wide range of solid tumors and blood cancers. While immunotherapy is not a new branch of oncology, it has rapidly evolved into one of the most dynamic and promising areas in medicine. This review article delves into the pivotal discoveries that have shaped our current understanding of how the immune system interacts with cancer. Key breakthroughs include the development of checkpoint inhibitors, monoclonal antibodies, CAR-T cell therapies, and anti-cancer vaccines. Current research in immunotherapy, such as studies on the gut microbiome, the combination of checkpoint inhibitors, and gene sequencing, is paving the way for personalized cancer treatments. This opens up a realm of exciting possibilities for the future, offering hope for continued innovation and improved outcomes for cancer patients.